Regulatory News
Wednesday, November 9, 2016
BRIEF-ARIAD announces phase 1/2 trial data on investigational drug Brigatinib Published in The Lancet Oncology
* ARIAD announces phase 1/2 trial data on investigational
drug Brigatinib published in the Lancet Oncology
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment